United States · FDA National Drug Code directory
Loratadine
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 25000-021_adf6c78c-edb1-4ffb-a934-d8cb772e621f
- Product NDC
- 25000-021
- Form
- CAPSULE, LIQUID FILLED
- Composition / generic term
- Loratadine
- Labeler
- MARKSANS PHARMA LIMITED
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20161001
- Source listing expiry
- 20261231
Source-listed ingredients
- LORATADINE — 10 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 CAPSULE, LIQUID FILLED in 1 BOTTLE (25000-021-08) · 25000-021-08
- 600 CAPSULE, LIQUID FILLED in 1 BOTTLE (25000-021-13) · 25000-021-13
- 4 BAG in 1 BOX (25000-021-21) / 7500 CAPSULE, LIQUID FILLED in 1 BAG · 25000-021-21
- 28 CAPSULE, LIQUID FILLED in 1 BLISTER PACK (25000-021-34) · 25000-021-34
- 3 BLISTER PACK in 1 CARTON (25000-021-36) / 10 CAPSULE, LIQUID FILLED in 1 BLISTER PACK · 25000-021-36
- 8 CAPSULE, LIQUID FILLED in 1 BOTTLE (25000-021-46) · 25000-021-46
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →